4//SEC Filing
QUESTCOR PHARMACEUTICALS INC 4
Accession 0001209191-14-053201
CIK 0000891288operating
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:49 PM ET
Size
23.4 KB
Accession
0001209191-14-053201
Insider Transaction Report
Form 4
SILVERMAN LOU
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2014-08-14−15,214→ 0 totalExercise: $40.37Exp: 2022-05-09→ Common Stock (15,214 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−17,500→ 0 totalExercise: $14.73Exp: 2020-12-31→ Common Stock (17,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−13,333→ 0 totalExercise: $4.75Exp: 2019-12-31→ Common Stock (13,333 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−13,437→ 0 totalExercise: $14.73Exp: 2020-12-31→ Common Stock (13,437 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−6,667→ 0 totalExercise: $4.08Exp: 2019-12-09→ Common Stock (6,667 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−3,750→ 0 totalExercise: $10.16Exp: 2020-06-30→ Common Stock (3,750 underlying) - Disposition to Issuer
Common Stock
2014-08-14−24,183→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−10,000→ 0 totalExercise: $9.47Exp: 2020-05-27→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−9,203→ 0 totalExercise: $34.86Exp: 2023-05-23→ Common Stock (9,203 underlying)
Footnotes (3)
- [F1]Pursuant to Agreement and Plan of Merger, dated April 5, 2014 (the "Merger Agreement"), by and among Mallinckrodt plc ("Mallinckrodt"), Quincy Merger Sub, Inc. and Questcor Pharmaceuticals, Inc. ("Questcor"), Mallinckrodt acquired Questcor in a merger transaction (the "Merger") which closed at 4:30 p.m. EST, on August 14, 2014 (the "Effective Time"). At the Effective Time, each share of Questcor common stock (except for certain shares defined in the Merger Agreement) converted into the right to receive, without interest, (a) $30.00 in cash and (b) 0.897 of an ordinary share of Mallinckrodt, in exchange for such share of Questcor common stock ("Merger Consideration").
- [F2]Pursuant to terms of the Merger, at the Effective Time, each Questcor stock option, whether vested or unvested, held by Questcor non-employee directors converted into the right to receive the Merger Consideration with respect to each share of Company common stock subject to such option immediately prior to the effective time of the Merger, net of the applicable exercise price.
- [F3]Fully exercisable.
Documents
Issuer
QUESTCOR PHARMACEUTICALS INC
CIK 0000891288
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000891288
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:49 PM ET
- Size
- 23.4 KB